Timothy Waje | Medical Microbiology | Best Researcher Award

Posted on by ScienceFather

Mr Timothy Waje | Medical Microbiology | Best Researcher Award

Timothy Waje At Abubakar Tafawa Balewa University Bauchi

Dr. Timothy Waje is a dedicated medical microbiologist with expertise in infectious disease epidemiology, public health research, and capacity development. With extensive experience in academic leadership, consultancy, and community health programs, he combines scientific rigor with a commitment to improving global health outcomes. Dr. Waje aspires to become a professor in medical microbiology, contributing to vaccine development and solutions for viral and bacterial health challenges.

Publication Profile

Education

Dr. Timothy Waje is currently pursuing a Doctor of Philosophy (Ph.D.) in Medical Microbiology at Abubakar Tafawa Balewa University, Bauchi, Nigeria. He holds a Master of Science (M.Sc.) in Medical Microbiology from Kaduna State University, Kaduna, Nigeria, completed in 2018 with a commendable CGPA of 4.60/5.00. His undergraduate degree, a Bachelor of Technology (B.Tech Hons) in Applied Microbiology, was also earned at Abubakar Tafawa Balewa University in 1998, graduating with a CGPA of 4.10/5.00. His academic training includes advanced courses in medical microbiology, epidemiology, biostatistics, and research methodology.

Professional Experience 🌟

Dr. Waje currently serves as the Provost of Lodestar School of Health and Technology, Kujama, Kaduna State, where he oversees administrative, academic, and operational functions. His role includes staff training, recruitment, and liaison with government and professional bodies, in addition to teaching microbiology and communicable disease control.

Previously, he has held consultancy roles with Sightsavers Nigeria, contributing to neglected tropical disease programs such as lymphatic filariasis and trachoma elimination. His work involved community mobilization, data management, field supervision, and training health workers. With over a decade of experience in the banking sector, he held managerial positions at Access Bank Plc and United Bank for Africa, where he honed his leadership, compliance, and team-building skills.

Research Interests:

Dr. Waje’s research interests focus on infectious disease epidemiology, particularly in vaccine research and development for common pathogens. He is dedicated to exploring molecular epidemiology, the genomic relationship between viruses and drug responses, and the intersection of viral replication, host cell inflammation, and related symptoms. His work also extends to improving emergency preparedness for viral disease outbreaks and human capacity development for future scientists.

Research Contributions:

Dr. Waje has authored multiple publications in peer-reviewed journals, including studies on cytomegalovirus, lymphatic filariasis, and genetic diversity in Campylobacter species. Notable works include:

  1. Occurrence of Cytomegalovirus Among Pregnant Antenatal Women Within Bauchi Metropolis, Nigeria (Clinical Epidemiology and Global Health, 2025).
  2. A Review of Epidemiology of Lymphatic Filariasis in Nigeria (Pan African Medical Journal, 2024).
  3. Genetic Diversity, Virulence, and Resistance Genes Among Campylobacter Species in Nigeria: A Review (Current Clinical Microbiology Reports, 2024).

Metrics and Memberships:

Dr. Waje’s research outputs are recognized internationally, with publications indexed in high-impact journals. He is an active member of the American Society for Microbiology (Global Outreach Membership) and the International Society for Infectious Diseases (ISID).

Publication Top Notes

1. Occurrence of Cytomegalovirus among Pregnant Antenatal Women within Bauchi Metropolis, Nigeria

  • Authors: Waje, T., Iliyasu, M.Y., Umar, A.F., Agbo, E.B.
  • Journal: Clinical Epidemiology and Global Health (2025), Volume 32, Article 101915.
  • Summary: This article investigates the prevalence of Cytomegalovirus (CMV) infection among pregnant women in Bauchi, Nigeria. It highlights the epidemiological significance of CMV in antenatal care and provides insights into its potential impact on maternal and fetal health.
  • Citations: None reported.

2. Occurrence of Genetic Diversity, Virulence, and Resistance Genes Among Campylobacter Species in Nigeria: A Review

  • Authors: Waje, T., Iliyasu, C., Yaki, L.M., Auta, I.K.
  • Journal: Current Clinical Microbiology Reports (2024), Volume 11, Issue 2, Pages 35–42.
  • Summary: This review examines the genetic diversity, virulence factors, and antimicrobial resistance genes in Campylobacter species identified in Nigeria. It emphasizes the importance of molecular surveillance for improving public health strategies against Campylobacter-associated infections.
  • Citations: None reported.

3. A Review of Epidemiology of Lymphatic Filariasis in Nigeria

  • Authors: Waje, T., Iliyasu, C., Yaki, L.M., Auta, I.K.
  • Type: Review (Open Access)
  • Summary: This paper reviews the epidemiological aspects of lymphatic filariasis in Nigeria, including its prevalence, transmission, control measures, and public health challenges. The article aims to provide comprehensive data to guide eradication programs in endemic regions.

Conclusion

Dr. Timothy Waje’s outstanding contributions to medical microbiology, leadership, and dedication to improving public health make him a compelling candidate for the Best Researcher Award. His work demonstrates a balance of academic rigor and practical application, particularly in addressing infectious diseases that impact vulnerable populations.

By addressing areas for improvement, such as enhancing research visibility and fostering international collaboration, Dr. Waje can further solidify his position as a leading figure in medical microbiology. Recognizing his achievements with this award would not only honor his contributions but also inspire continued excellence in the field.

 

 

Asal Katebi | Infectious disease | Best Researcher Award

Posted on by ScienceFather

Dr. Asal Katebi | Infectious disease | Best Researcher Award

Medical Immunology, Pasteur Institute of Iran

Asal Katebi, Ph.D., is an Assistant Professor at the Pasteur Institute of Iran, specializing in Medical Immunology. Her research focuses on developing therapeutic vaccines for infectious diseases like leishmaniasis using nanoparticle formulations and TLR agonists. She holds a Ph.D. in Medical Immunology from Isfahan University of Medical Sciences and has extensive experience in molecular biology and immunotherapy.

Profile

Google Scholar

 

📚 Education:

Asal Katebi completed her Ph.D. in Medical Immunology at Isfahan University of Medical Sciences, where she conducted research on therapeutic vaccines for leishmaniasis. She also holds an M.Sc. in Medical Immunology from Tehran University of Medical Sciences and a B.Sc. in Microbiology from Islamic Azad University, North Tehran Branch.

👩‍💼 Experience:

Dr. Katebi’s professional journey includes significant roles at the Pasteur Institute of Iran, where she conducts research, mentors students, and teaches courses in immunology. She has expertise in molecular immunology, nanoparticle preparation, cell culture techniques, and has contributed to numerous research projects aimed at combating infectious diseases.

🔬 Research Interests:

Her research interests span molecular immunology and immunotherapy, focusing on vaccine development against leishmaniasis. Dr. Katebi is particularly interested in nanoparticle-based delivery systems, TLR agonists, and the immunomodulatory effects of extracellular vesicles derived from parasites.

🏆 Awards:

Asal Katebi has received recognition for her contributions to immunological research, including awards for her presentations at international congresses. Notably, she was honored for her work on the SLA-R848-Pam3CSK4 combination as a therapeutic vaccine for cutaneous leishmaniasis.

📄 Publications:

Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection – Molecular Immunology, 2015

Leishmania tarentolae secreting PpSP15 and CpG motifs protects against Leishmania major infection – European Journal of Immunology, 2019

Combinatorial delivery of antigen and TLR agonists via PLGA nanoparticles modulates Leishmania major-infected macrophages – Biomedicine & Pharmacotherapy, 2021